{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:54:31Z","timestamp":1787673271350,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.preghy.2021.10.005","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T11:49:10Z","timestamp":1635508150000},"page":"110-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["External validation of first trimester combined screening for pre-eclampsia in Brazil: An observational study"],"prefix":"10.1016","volume":"26","author":[{"given":"Karina B. de C.","family":"Rezende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita G.","family":"Bornia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Rolnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Joffre","family":"Amim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristos","family":"Pritsivelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel M.P.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza B.","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel A.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina M.P.","family":"L' Hotellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Jos\u00e9 L.A.","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2021.10.005_b0005","unstructured":"World Health Organization. Make every mother and child count. World Health Rep. Geneva, WHO; 2005. Available at: http:\/\/www. who.int\/whr\/2005\/whr2005_en.pdf. Accessed November 29, 2016."},{"key":"10.1016\/j.preghy.2021.10.005_b0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/ldg005","article-title":"Pre-eclampsia and the hypertensive disorders of pregnancy","volume":"67","author":"Duley","year":"2003","journal-title":"Br. Med. Bull"},{"issue":"4","key":"10.1016\/j.preghy.2021.10.005_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.preghy.2016.08.229","article-title":"Preeclampsia: prevalenceand perinatal repercussions in a University Hospital in Rio de Janeiro, Brazil","volume":"6","author":"Rezende","year":"2016","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.10.005_b0020","unstructured":"A. Liu, S.W. Wen, J. Bottomley, M.C. Walker, G. Smith, Utilization of healthcare services of pregnant women complicated."},{"issue":"3","key":"10.1016\/j.preghy.2021.10.005_b0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiol.00043.2008","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"Wang","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.preghy.2021.10.005_b0030","unstructured":"World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011. Available at: http:\/\/whqlibdoc.who.int\/ publications\/2011\/9789241548335_eng.pdf."},{"issue":"1","key":"10.1016\/j.preghy.2021.10.005_b0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FM9.0000000000000005","article-title":"Screening and prevention of preeclampsia","volume":"1","author":"Poon","year":"2019","journal-title":"Maternal Fetal Med."},{"issue":"7","key":"10.1016\/j.preghy.2021.10.005_b0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.preghy.2021.10.005_b0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am. J. ObstetGynecol."},{"issue":"1 Suppl 1","key":"10.1016\/j.preghy.2021.10.005_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.preghy.2021.10.005_b0055","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: Royal College of Obstetricians and Gynaecologists Press; 2010. (NICE Clinical Guidelines, 107)."},{"issue":"2 pt.1","key":"10.1016\/j.preghy.2021.10.005_b0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2021.10.005_b0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.10.005_b0070","unstructured":"Bornia RG, Costa JIB, Amim JJ. Protocolos assistenciais: Maternidade Escola Universidade Federal do Rio de Janeiro. Rio de Janeiro: POD; 2013."},{"key":"10.1016\/j.preghy.2021.10.005_b0075","first-page":"1","article-title":"Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study","author":"Guy","year":"2020","journal-title":"Br. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2021.10.005_b0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/jhh.2009.45","article-title":"Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach","volume":"24","author":"Poon","year":"2010","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"10.1016\/j.preghy.2021.10.005_b0085","first-page":"171","article-title":"A competing risks model in early screening for preeclampsia","volume":"32","author":"Wright","year":"2012","journal-title":"FetalDiagnTher."},{"issue":"1","key":"10.1016\/j.preghy.2021.10.005_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.preghy.2021.10.005_b0095","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am. J. ObstetGynecol."},{"issue":"1","key":"10.1016\/j.preghy.2021.10.005_b0100","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.10.005_b0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust. NZJ ObstetGynaecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.10.005_b0110","doi-asserted-by":"crossref","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.10.005_b0115","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2017.14498","article-title":"First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm","volume":"147","author":"Mosimann","year":"2017","journal-title":"Swiss Med. Wkly"},{"issue":"4","key":"10.1016\/j.preghy.2021.10.005_b0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000477934","article-title":"First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the Fetal Medicine Foundation-Algorithm","volume":"43","author":"Guizani","year":"2018","journal-title":"Fetal Diagn. Ther."},{"issue":"2","key":"10.1016\/j.preghy.2021.10.005_b0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/14767058.2017.1378332","article-title":"Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population","volume":"32","author":"Lobo","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.preghy.2021.10.005_b0130","first-page":"64","article-title":"External validation of the fetal medicine foundation algorithm for the prediction of preeclampsia in a Brazilian population","volume":"17","author":"Rezende","year":"2019","journal-title":"PregnancyHypertens."},{"issue":"9","key":"10.1016\/j.preghy.2021.10.005_b0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1471-0528.1975.tb00710.x","article-title":"A critical evaluation of sonar crown rump length measurements","volume":"82","author":"Robinson","year":"1975","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.preghy.2021.10.005_b0140","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/uog.5157","article-title":"Uterine artery doppler at 11+ 0 to 13+ 6 weeks in the prediction of pre-eclampsia","volume":"30","author":"Plasencia","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2021.10.005_b0145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/uog.15815","article-title":"Mean arterial pressure at 12, 22, 32 and 36 weeks\u2019 gestation in screening for pre-eclampsia","volume":"47","author":"Tayyar","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.10.005_b0150","unstructured":"The Fetal Medicine Foundation. Available at: https:\/\/courses.fetalmedicine.com\/user\/get_license\/. Accessed June 06, 2018."},{"issue":"1","key":"10.1016\/j.preghy.2021.10.005_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2021.10.005_b0160","unstructured":"Wright D, Nicolaides KH. Institute of Health Research, University of Exeter, Exeter, UK Harris Birthright Research Centre for Fetal Medicine, King\u2019s College Hospital, London, UK. Letters to the Editor to Guy et al. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study: 2020 July 23. BJOG Exchange. Doi: 10.1111\/1471-0528.16445. Availableat: https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1471-0528.16445."},{"issue":"6","key":"10.1016\/j.preghy.2021.10.005_b0165","first-page":"743","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound ObstetGynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.10.005_b0170","first-page":"756","article-title":"Multicenter screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks' gestation: comparison to NICE guidelines and ACOG recommendations","volume":"49","author":"O' Gorman","year":"2017","journal-title":"Ultrasound ObstetGynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.10.005_b0175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/uog.19019","article-title":"ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm","volume":"51","author":"Poon","year":"2018","journal-title":"Ultrasound Obstet Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.10.005_b0180","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.10.005_b0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The, \u201cgreat obstetrical syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.preghy.2021.10.005_b0190","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.ajpath.2016.08.010","article-title":"Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an n vitro model of early-onset preeclampsia","volume":"186","author":"Panagodage","year":"2016","journal-title":"Am J Pathol."},{"issue":"5","key":"10.1016\/j.preghy.2021.10.005_b0195","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921005298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:54:58Z","timestamp":1761897298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921005298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"alternative-id":["S2210778921005298"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.10.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External validation of first trimester combined screening for pre-eclampsia in Brazil: An observational study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}